Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard Care

计划入组 8 人 · 首次发布于 2018 年 2 月 8 日

Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer

首次发布于 2021 年 3 月 4 日

HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

计划入组 774 人 · 首次发布于 2023 年 6 月 15 日

recombinant human keratinocyte growth factor

recombinant human nerve growth factor(Oxervate)

Fibroblast growth factor-2

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Canopy Growth Corporation

Canada

Singapore Researchers Launch Clinical Trial Testing Novel Cell State Conversion Approach for Triple-Negative Breast Cancer

Growth Hormone Receptor Emerges as Promising Target for Therapy-Resistant Lung Cancer

Two-Step Growth Factor Treatment Unlocks Hidden Regenerative Capacity in Mammals